# Catalent Pharma Solutions, LLC - Inspection Records Source: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/d29a124f-fdcb-4108-9eac-661149b4d20e > Inspection records and compliance data for Catalent Pharma Solutions, LLC in Saint Petersburg, Florida. Access full analysis and detailed observations. --- ## Details - Name: Catalent Pharma Solutions, LLC - FEI Number: 1811396 - City: Saint Petersburg - State: Florida - Country Name: United States - Address Line 1: 2725 Scherer Dr N - Zip Code: 33716 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [483 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/511c9d12-351a-44a8-b9a2-bf7285abafc4) — source: FDA, date: January 30, 2026 - [483 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/93c4cc9c-fd83-4c26-9023-0b4c62c93c56) — source: FDA, date: January 30, 2026 - [FDA Inspection 1282788 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/3c033b5d-6772-4e48-87f5-c003b37a8034) — source: FDA, date: January 30, 2026 - [FDA Inspection 1282788 - Catalent Pharma Solutions, LLC - 2026-01-30](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/7aa64c50-f27a-49da-a63e-4d0bd26c9c4b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 30, 2026 - [FDA Inspection 1229815 - Catalent Pharma Solutions, LLC - 2024-05-30](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/c3186956-345e-4337-a3f1-30947d13d3f5) — classification: No Action Indicated (NAI), source: FDA, date: May 30, 2024 - [FDA Inspection 1229344 - Catalent Pharma Solutions, LLC - 2024-01-25](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/89878bd4-947c-4510-8ccf-a1be0821f108) — classification: No Action Indicated (NAI), source: FDA, date: January 25, 2024 - [483 - Catalent Pharma Solutions, LLC - 2023-07-21](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/b53d3803-0505-4856-999c-33b3e1fb1bda) — source: FDA, date: July 21, 2023 - [FDA Inspection 1210540 - Catalent Pharma Solutions, LLC - 2023-07-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/90d4bb7b-c5b9-412b-9f5a-2300c5e0499b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023 - [EIR - Catalent Pharma Solutions, LLC - 2019-08-28](https://www.keypedia.com/records/eir/catalent-pharma-solutions-llc/b67ab5e5-536c-40cb-a48e-316131669495) — source: FDA, date: August 28, 2019 - [FDA Inspection 1101180 - Catalent Pharma Solutions, LLC - 2019-08-28](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/75403390-fa81-4248-b533-acde008a2e64) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 28, 2019 - [483 - Catalent Pharma Solutions, LLC - 2019-02-22](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/c760f7e9-a3ed-4068-8e39-cf085acfd8af) — source: FDA, date: February 22, 2019 - [FDA Inspection 1080109 - Catalent Pharma Solutions, LLC - 2019-02-22](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/f65ec9d4-80a0-4c7e-8873-7b8eef0bdf8d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 22, 2019 - [483 - Catalent Pharma Solutions, LLC - 2018-06-14](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/c2a346ed-29f8-40bd-88dd-80e5da48f13c) — source: FDA, date: June 14, 2018 - [FDA Inspection 1056856 - Catalent Pharma Solutions, LLC - 2018-06-14](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/b2f1443c-74b0-4599-94e2-3f0c3724916b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 14, 2018 - [483 - Catalent Pharma Solutions, LLC - 2016-03-25](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/70f13562-b3ef-4e98-aae6-b2b576bd35e7) — source: FDA, date: March 25, 2016 - [FDA Inspection 967738 - Catalent Pharma Solutions, LLC - 2016-03-25](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/8b045f00-6601-4ee8-9673-995f2097d482) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016 - [FDA Inspection 967738 - Catalent Pharma Solutions, LLC - 2016-03-25](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/d7057bd5-7353-4188-bcd5-bea0eea50b96) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2016 ## Related Companies - [Fresenius Kabi USA, LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/6b662e1b-3996-48b4-a517-0d555d32a380) - [Nang Kuang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nang-kuang-pharmaceutical-co-ltd/bdb8b0bb-4a8d-4f50-a72d-e250626e2818) - [APL HEALTHCARE LIMITED](https://www.keypedia.com/companies/apl-healthcare-limited/d13ff022-135e-4790-b958-7f0667d985ab) - [Sentiss Pharma Pvt. Ltd.](https://www.keypedia.com/companies/sentiss-pharma-pvt-ltd/9b26b814-70c1-46e9-bc82-9bec425fd2b7) - [Amneal Complex Products Research LLC](https://www.keypedia.com/companies/amneal-complex-products-research-llc/a2be8996-ba6b-481d-b935-b75129500758) - [KOFU FACTORY OF TERUMO CORP.](https://www.keypedia.com/companies/kofu-factory-of-terumo-corp/e0540434-5dcb-4074-851e-f91bd8bfbbf1) - [MSN Laboratories Private Limited](https://www.keypedia.com/companies/msn-laboratories-private-limited/9b211d46-5c01-422b-b597-7105eb5c6d51) - [Oxford Biomedica (UK) Limited](https://www.keypedia.com/companies/oxford-biomedica-uk-limited/12d29c20-d7d1-4ab9-830f-5d9f25a506ad) - [Alnylam Pharmaceuticals Inc.](https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8) - [Nucrogene Inc](https://www.keypedia.com/companies/nucrogene-inc/501df133-f224-4158-9017-370447fc29a5) ## Related Officers - [Ileana Barreto-Petit](https://www.keypedia.com/people/ileana-barreto-petit/e5c865ac-14a2-47d4-954b-464a865e8684) - [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3) - [Christos G. Tsingelis](https://www.keypedia.com/people/christos-g-tsingelis/a0bacf2c-cf1f-4c34-996a-fcc1aa371610) - [Jennifer Lalama](https://www.keypedia.com/people/jennifer-lalama/5ebc4da1-62ac-4b15-89a8-e18b0606e0ff) - [Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre](https://www.keypedia.com/people/jessica-l-pressley/2c190e50-81bd-4015-95f0-7177beb363bd)